The U.S. Food and Drug Administration has placed a full clinical hold on late-stage clinical trials of Aardvark Therapeutics’ oral therapy candidate ARD-101 in patients with Prader-Willi syndrome (PWS) and hyperphagia, or insatiable hunger. The company had voluntarily paused…
Discussion
There is a corner of my yard that quietly tells the story of four generations. The peonies blooming there started in my great-grandmother’s garden. When she passed, my grandmother replanted them in her backyard. When she was gone, I knew I wanted them in my yard. Every May, those same…
Tonix Pharmaceuticals has pushed back the planned start of a Phase 2 clinical trial testing its oxytocin-containing TNX-2900 nasal spray in children and adolescents with Prader-Willi syndrome (PWS). Tonix had expected the U.S.-based study, which has been cleared by the U.S. Food and Drug Administration (FDA), to start…
Prader-Will syndrome is a rare and complex genetic condition that results in a variety of physical and mental symptoms. Learn more about the disease here.
Prader-Willi is caused by genetic changes in a particular area of chromosome 15. Learn more about what causes the disease here.
Symptoms of Prader-Willi range from physical impairments to cognitive and behavioral issues. Learn more about the symptoms of the disease here.
Get regular updates to your inbox.
